Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 7.47
(-0.53%)
CNY 7.47
(-0.53%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 22.03 Million CNY | -61.2% |
| 2022 | 56.8 Million CNY | 3.43% |
| 2021 | 54.92 Million CNY | 90.83% |
| 2020 | 28.78 Million CNY | -37.83% |
| 2019 | 46.29 Million CNY | 135.54% |
| 2018 | -130.26 Million CNY | -173.14% |
| 2017 | 178.1 Million CNY | -24.0% |
| 2016 | 234.35 Million CNY | 13.88% |
| 2015 | 205.79 Million CNY | 39.11% |
| 2014 | 147.93 Million CNY | 24.74% |
| 2013 | 118.59 Million CNY | 19.09% |
| 2012 | 99.58 Million CNY | 28.92% |
| 2011 | 77.24 Million CNY | 53.85% |
| 2010 | 50.2 Million CNY | 129.3% |
| 2009 | 21.89 Million CNY | 4.82% |
| 2008 | 20.89 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -25.42 Million CNY | -522.6% |
| 2024 Q3 | -19.61 Million CNY | 22.87% |
| 2024 Q1 | 6.01 Million CNY | 111.41% |
| 2023 Q4 | -52.74 Million CNY | -851.08% |
| 2023 Q1 | 31.39 Million CNY | 821.41% |
| 2023 FY | 22.03 Million CNY | -61.2% |
| 2023 Q2 | 36.36 Million CNY | 15.85% |
| 2023 Q3 | 7.02 Million CNY | -80.69% |
| 2022 Q3 | 13.88 Million CNY | 23.23% |
| 2022 FY | 56.8 Million CNY | 3.43% |
| 2022 Q1 | 5 Million CNY | -36.03% |
| 2022 Q2 | 11.27 Million CNY | 125.03% |
| 2022 Q4 | -4.35 Million CNY | -131.33% |
| 2021 Q2 | 15.7 Million CNY | -11.45% |
| 2021 Q4 | 7.82 Million CNY | -42.66% |
| 2021 FY | 54.92 Million CNY | 90.83% |
| 2021 Q1 | 17.73 Million CNY | 112.12% |
| 2021 Q3 | 13.65 Million CNY | -13.06% |
| 2020 Q1 | -23.34 Million CNY | 44.58% |
| 2020 FY | 28.78 Million CNY | -37.83% |
| 2020 Q2 | -15.94 Million CNY | 31.7% |
| 2020 Q4 | -146.36 Million CNY | -963.8% |
| 2020 Q3 | -13.75 Million CNY | 13.7% |
| 2019 FY | 46.29 Million CNY | 135.54% |
| 2019 Q4 | -42.11 Million CNY | -889.13% |
| 2019 Q3 | 5.33 Million CNY | 677.79% |
| 2019 Q2 | 686.18 Thousand CNY | -97.22% |
| 2019 Q1 | 24.71 Million CNY | 111.96% |
| 2018 Q1 | 49.54 Million CNY | 476.93% |
| 2018 FY | -130.26 Million CNY | -173.14% |
| 2018 Q3 | 13.48 Million CNY | 0.55% |
| 2018 Q4 | -206.7 Million CNY | -1632.95% |
| 2018 Q2 | 13.4 Million CNY | -72.93% |
| 2017 Q4 | 8.58 Million CNY | -87.87% |
| 2017 Q2 | 45.13 Million CNY | -15.78% |
| 2017 FY | 178.1 Million CNY | -24.0% |
| 2017 Q3 | 70.77 Million CNY | 56.8% |
| 2017 Q1 | 53.59 Million CNY | 1.58% |
| 2016 Q2 | 60.32 Million CNY | -0.93% |
| 2016 Q4 | 52.76 Million CNY | -12.61% |
| 2016 Q1 | 60.89 Million CNY | 14.3% |
| 2016 Q3 | 60.37 Million CNY | 0.09% |
| 2016 FY | 234.35 Million CNY | 13.88% |
| 2015 Q4 | 53.27 Million CNY | 7.42% |
| 2015 Q3 | 49.59 Million CNY | -5.01% |
| 2015 Q2 | 52.2 Million CNY | 2.94% |
| 2015 FY | 205.79 Million CNY | 39.11% |
| 2015 Q1 | 50.71 Million CNY | 59.19% |
| 2014 FY | 147.93 Million CNY | 24.74% |
| 2014 Q4 | 31.85 Million CNY | -25.3% |
| 2014 Q3 | 42.65 Million CNY | 33.08% |
| 2014 Q2 | 32.05 Million CNY | -22.53% |
| 2014 Q1 | 41.37 Million CNY | 18.6% |
| 2013 Q3 | 30.75 Million CNY | 18.19% |
| 2013 Q1 | 26.94 Million CNY | 0.0% |
| 2013 FY | 118.59 Million CNY | 19.09% |
| 2013 Q4 | 34.88 Million CNY | 13.44% |
| 2013 Q2 | 26.01 Million CNY | -3.45% |
| 2012 FY | 99.58 Million CNY | 28.92% |
| 2011 Q4 | 14.73 Million CNY | 0.0% |
| 2011 FY | 77.24 Million CNY | 53.85% |
| 2010 FY | 50.2 Million CNY | 129.3% |
| 2009 FY | 21.89 Million CNY | 4.82% |
| 2008 FY | 20.89 Million CNY | 0.0% |